Allianz Cancer Protection Plan Offers Flexible Premium Payment Terms

The newly launched Allianz Cancer Protect plan offers Malaysians flexibility in managing cancer diagnosis.

According to the Ministry of Health, in Malaysia, at least 60 percent of cancer cases are detected at Stage Three and Stage Four. Furthermore, the Global Cancer Observatory 2018 report revealed there were 43,837 new cancer cases in Malaysia last year, thus improving cancer mortality hinges on awareness, early diagnosis and access to treatment.

Allianz Malaysia Berhad’s Chief Executive Officer Zakri Khir said, “When it comes to cancer, one of the biggest challenges is still affordability of treatment. And that’s true anywhere in the world. The economic burden brought on by the disease can be grave. And with escalating medical costs, those diagnosed with cancer are often resigned to making difficult decisions to give themselves a fighting chance to battle the disease.”
“With Allianz Cancer Protect, it is all about affording the policyholder with viable options for treatment. Having options when seeking medical treatment is like a lifeline. And when you are staring down cancer, it can be a game-changer. Allianz Cancer Protect gives policyholders the option to choose the type of plan and coverage, ultimately giving them the power to choose what suits them the best,” added Zakri.

Allianz Cancer Protect offers four plans – Plan 125 (for an Insured Amount of (RM125,000); Plan 250 (RM250,000); Plan 375 (RM375,000); and Plan 500 (RM500,000) – and a choice of Lump Sum Insured Amount (Coverage A and Coverage B) or Overseas Medical Treatment Benefit (with Coverage B only).

Coverage A and Coverage B offers the following:

Lump Sum Insured Amount (Coverage A)

  • If diagnosed with cancer, the Insured will receive 200 percent of the Insured Amount upon approval of the claim

Overseas Medical Treatment Benefit (Coverage B)

  • If diagnosed with cancer, the Insured will receive 100 percent of the Insured Amount upon approval of the claim
  • Upon approval of the claim and payout of the first 100 percent of Insured Amount, an Indemnification Period of 36 months shall start where the Insured Person can choose to either:
  1. Receive an additional 100 percent of Insured Amount (after which the Policy shall be subsequently terminated); or
  2. Activate the Overseas Medical Treatment Benefit

For Coverage B, the 36-month Indemnification Period allows patients to seek a second opinion.

Besides that, Coverage B also provided policyholders an Overseas Medical Treatment Benefit Annual Limit of up to USD2 million and an Overseas Medical Treatment Benefit Overall Limit of USD4 million.

 

 

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Halal Street UK and Alliance Islamic Bank sign MOU to tailored programmes to SMEs

Halal Street UK,  an online store for Malaysian products in the United Kingdom has signed a multi-year Memorandum of Understanding with Alliance...

Shopee and Visa sign five-year strategic partnership to offer MSMEs more digital opportunities

E-commerce platform, Shopee and Visa has announced a five-year regional strategic partnership that will encourage greater participation in Southeast Asia’s digital economy,...

MADX Panel selects IBM Cloud to offer enhanced digital services to Malaysian enterprises

IBM has announced that MADX Panel, the leading Malaysian fintech software solutions company, is implementing IBM Cloud solutions to improve digital services...

AirAsia Digital partners with Google to launch Redbeat Academy

AirAsia Digital, in partnership with Google, has launched the Redbeat Academy as part of their continued digital transformation journey.

Better e-commerce service for higher consumer spending

By Farhan Kamarulzaman, As the usage of e-commerce platforms by Malaysians is on the increase during the Covid-19 period,...

Must read

Unprecedented times with Covid-19, business decision makers prepare for a soft landing and focus on employee retention

By Andrew Seow, Regional General Manager, Rimini Street Southeast Asia and Greater China, The Covid-19 pandemic is attacking health...

Caring for young hearts

By Dr. Marhisham Che Mood, Head of Paediatric and Congenital Heart Centre (PCHC) & Consultant Paediatric Cardiologist, While heart...

PropTech and the pandemic

By Adrian Un, CEO, SkyBridge International Digitisation and PropTech (property technology) have been buzzwords in recent years, but following...

Empower local agility to unlock new business models post-Covid-19

By Scott Hensarling, Senior Client Partner and Tobjorn Karlsson, Senior Client Partner, Korn Ferry, 2020 has challenged many assumptions...